Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study

BMC Medical Genetics

Research Article

Stefan Blankenberg¹  Renate Schnabel¹  Thomas Munzel²  Hans J Rupprecht²  Christoph Bickel³  Noémie Saut⁴  Pierre-Emmanuel Morange⁴  William Cohen⁴  Choumous Kallel⁴  David-Alexandre Tregouet⁵ 

[1] Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany;Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany;Federal Armed Forces Central Hospital Koblenz, Koblenz, Germany;INSERM UMR_1062, Aix-Marseille Université, F-13385, Marseille, France;INSERM, UMR_S 937; Institute of Cardiometabolism And Nutrition (ICAN), Université Pierre et Marie Curie Paris 6, F-75013, Paris, France;

关键词: \;    Haemostasis;    Protein C;    Endothelial protein C receptor;    Coronary artery disease;   

DOI  :  10.1186/1471-2350-13-103

 received in 2012-07-31, accepted in 2012-10-12,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundBlood coagulation is an essential determinant of coronary artery disease (CAD). Soluble Endothelial Protein C Receptor (sEPCR) may be a biomarker of a hypercoagulable state. We prospectively investigated the relationship between plasma sEPCR levels and the risk of cardiovascular events (CVE).MethodsWe measured baseline sEPCR levels in 1673 individuals with CAD (521 with acute coronary syndrome [ACS] and 1152 with stable angina pectoris [SAP]) from the AtheroGene cohort. During a median follow up of 3.7 years, 136 individuals had a CVE. In addition, 891 of these CAD patients were genotyped for the PROCR rs867186 (Ser219Gly) variant.ResultsAt baseline, sEPCR levels were similar in individuals with ACS and SAP (median: 111 vs. 115 ng/mL respectively; p=0.20). Increased sEPCR levels were found to be associated with several cardiovascular risk factors including gender (p=0.006), soluble Tissue Factor levels (p=0.0001), diabetes (p=0.0005), and factors reflecting impaired renal function such as creatinine and cystatin C (p<0.0001). sEPCR levels were not significantly associated with the risk of CVE (median: 110 and 114 ng/mL in individuals with and without future CVE respectively; p=0.68). The rs867186 variant was found to explain 59% of sEPCR levels variability (p<10-200) but did not associate with CVE risk.ConclusionOur findings show that in patients with CAD, circulating sEPCR levels are related to classical cardiovascular risk factors and renal impairment but are not related to long-term incidence of CVE.

【 授权许可】

Unknown   
© Kallel et al.; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.